Patents by Inventor Nail Burnashev

Nail Burnashev has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modulators of intracellular chloride concentration for treating fragile X syndrome
    Patent number: 10201507
    Abstract: A composition for treating Fragile X syndrome in a subject in need thereof, wherein the composition includes an effective amount of a modulator of a chloride transporter.
    Type: Grant
    Filed: November 15, 2013
    Date of Patent: February 12, 2019
    Assignees: NEUROCHLORE, INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), UNIVERSITE AIX MARSEILLE, CENTRE HOSPITALIER UNIVERSITAIRE DE BREST
    Inventors: Yehezkel Ben-Ari, Eric Lemonnier, Nail Burnashev, Roman Tyzio
  • COMPOSITIONS
    Publication number: 20160354402
    Abstract: The invention provides a dinucleoside polyphosphate analogue, or a pharmaceutically acceptable salt thereof, for use as an anticonvulsant and/or seizure suppressant, in particular in the treatment or prevention of (e.g. juvenile) epilepsy.
    Type: Application
    Filed: November 27, 2014
    Publication date: December 8, 2016
    Inventors: Andrew David Miller, Natalya Lozovaya, Nail Burnashev, Rashid Giniatullin
  • MODULATORS OF INTRACELLULAR CHLORIDE CONCENTRATION FOR TREATING FRAGILE X SYNDROME
    Publication number: 20150335600
    Abstract: A composition for treating Fragile X syndrome in a subject in need thereof, wherein the composition includes an effective amount of a modulator of a chloride transporter.
    Type: Application
    Filed: November 15, 2013
    Publication date: November 26, 2015
    Inventors: Yehezkel BEN-ARI, Eric LEMONNIER, Nail BURNASHEV, Roman TYZIO
  • DINUCELOSIDE POLYPHOSPHATES FOR THE TREATMENT OF PAIN
    Publication number: 20150119352
    Abstract: The invention provides a dinucleoside polyphosphate analogue, or a pharmaceutically acceptable salt thereof, for use in the inhibition (or down-regulation) of a pain, via a transducing ATP-gated P2X3 receptor, often by means of high-affinity desensitisation (HAD) mechanism.
    Type: Application
    Filed: May 24, 2013
    Publication date: April 30, 2015
    Applicant: GlobalAcornLtd.
    Inventors: Andrew David Miller, Natalya Lozovaya, Nail Burnashev, Rashid Giniatullin